Postinfarction ventricular septal rupture (VSR) is a serious and potentially life-threatening complication that can occur after a myocardial infarction.
The clinical manifestations of these complications vary and are contingent on the location of the rupture, which can affect the free wall of either the ventricle, the interventricular septum, or the papillary muscles.
Post-myocardial infarction VSR is a feared complication and is associated with significant morbidity and mortality in individuals experiencing ST-elevation myocardial infarction.
Epidemiology
Post-myocardial infarction ventricular septal rupture (VSR) is observed in 1% to 2% of patients with ST-elevation myocardial infarction when reperfusion therapy is not administered and in 0.2% to 0.34% of patients receiving fibrinolytic therapy.
Among those undergoing reperfusion therapy, the occurrence is more frequent in individuals treated with fibrinolytic therapy than percutaneous coronary intervention. The incidence of VSR rises to 3.8% in STEMI patients experiencing cardiogenic shock as a complication.
Anatomy
Pathophysiology
The pathophysiology of postinfarction ventricular septal rupture (VSR) is rooted in the aftermath of a myocardial infarction. In the context of postinfarction VSR, the ventricular septum, which is the muscular wall separating the left and right ventricles of the heart, becomes particularly vulnerable. The infarction-induced ischemia weakens the septum, making it susceptible to rupture.
This weakening process is exacerbated by the inflammatory response and enzymatic activity associated with myocardial infarction. As the ventricular septum weakens, the pressure within the left ventricle increases. The combination of heightened pressure and structural vulnerability can lead to the formation of a tear or rupture in the septum. This rupture creates a direct communication between the left and right ventricles, allowing blood to flow between these chambers.
The pathophysiological consequences of postinfarction VSR are profound. The abnormal communication disrupts the normal flow of blood within the heart, leading to complications such as acute heart failure, pulmonary edema, and cardiogenic shock. The severity of these complications is often contingent on the size and location of the septal rupture.
Etiology
Ventricular septal rupture (VSR) is prevalent in an older demographic, particularly among females, those with hypertension, individuals with chronic kidney disease, and those without a history of smoking. It frequently manifests in the context of a primary myocardial infarction when reperfusion therapy is delayed or unavailable.
Angiographic assessments typically reveal an absence of collateral circulation to the infarct zone. The incidence of VSR tends to be higher in individuals experiencing their first myocardial infarction, especially when reperfusion therapy is not promptly administered. Notably, the absence of prior smoking history further contributes to the likelihood of VSR occurrence.
Contrarily, patients with documented evidence of diabetes mellitus, chronic angina, or a history of previous myocardial infarction exhibit a reduced propensity for septal rupture. This diminished risk is attributed to the protective effects of myocardial preconditioning induced by prior ischemic events, which decreases the likelihood of extensive myocardial necrosis and subsequent septal rupture.
Genetics
Prognostic Factors
VSR is associated with high morbidity and mortality rates. Early surgical intervention is crucial for improving outcomes. VSR is reported to occur more commonly in individuals treated with fibrinolytic therapy as opposed to percutaneous coronary intervention.
Clinical History
Patients with ventricular septal rupture (VSR) often have a history of recent myocardial infarction (MI). The clinical history may include details about the type of MI (ST-elevation myocardial infarction or non-ST-elevation myocardial infarction), any delays in receiving reperfusion therapy, and the presence of other cardiovascular risk factors.
VSR commonly presents with signs of cardiogenic shock, characterized by hypotension, tachycardia, and inadequate tissue perfusion. This is a critical manifestation reflecting the hemodynamic impact of the septal rupture. Patients may experience dyspnea, reflecting the development of acute heart failure and pulmonary congestion.
Due to compromised cardiac output, patients may exhibit symptoms of fatigue, weakness, and exercise intolerance. While the initial myocardial infarction may have presented with chest pain, the rupture of the ventricular septum may contribute to persistent or recurrent chest discomfort.
Physical Examination
One of the hallmark signs of VSR is the presence of a new holosystolic murmur. This murmur is typically heard at the lower left sternal border and may radiate to other areas of the chest. It is a result of the abnormal communication between the left and right ventricles caused by the septal rupture. Due to the hemodynamic consequences of VSR, patients often exhibit tachycardia.
The heart rate may be out of proportion to the degree of fever if present. VSR can lead to hemodynamic instability, resulting in low blood pressure. In advanced cases, jugular venous distension may be observed, reflecting increased central venous pressure due to compromised cardiac output. The presence of crackles on lung auscultation may indicate the development of pulmonary edema.
This occurs as a consequence of acute heart failure and the backflow of blood into the lungs. Edema in the extremities, particularly in the ankles and lower legs, may be present due to fluid retention and congestion resulting from heart failure. Hepatojugular reflux, characterized by an increase in jugular venous pressure upon sustained pressure applied to the liver, may be observed. This is another sign of increased right-sided heart pressure.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Myocardial Infarction
Infective Endocarditis
Pericardial Tamponade
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
The treatment of ventricular septal rupture (VSR) is primarily centered around urgent surgical closure, representing the gold standard intervention. Prompt surgical repair is crucial to address the communication between the left and right ventricles, mitigate hemodynamic compromise, and reduce associated morbidity and mortality.
Some considerations, such as allowing for tissue healing before surgery, have been debated, but the reported lower surgical mortality rates may be influenced by selection bias. Surgical mortality tends to be higher in patients with inferior myocardial infarction (MI) compared to those with anterior infarcts, attributed to more significant technical challenges and the frequent need for concomitant mitral valve repair in cases of basal septal rupture with coexisting mitral regurgitation.
While surgery remains the dominant approach, there is a growing interest in percutaneous closure, especially in patients with high surgical risk, reflecting a shift in therapeutic strategies. The choice between surgical and percutaneous closure is nuanced. It depends on factors such as the patient’s overall health and the specific characteristics of the septal rupture and associated cardiac abnormalities.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
The preferred treatment for ventricular septal rupture (VSR) is urgent surgical closure. Some researchers propose that delaying surgery may allow for the healing of delicate tissue, potentially reducing surgical mortality. However, it is important to note that reported lower surgical mortality rates could be influenced by selection bias.
Among patients with inferior myocardial infarction (MI), the surgical mortality rate is notably higher at 70%, in contrast to patients with anterior infarcts, where the mortality rate is around 30%. This discrepancy is attributed to the increased technical challenges associated with basal septal rupture in inferior MI cases, often necessitating concomitant mitral valve repair due to the frequent presence of coexisting mitral regurgitation.
Despite surgery being the established gold standard for post-MI VSR, there is a growing trend towards attempting percutaneous closure, particularly in patients deemed to be at high surgical risk. This reflects a shift in therapeutic approaches, acknowledging the potential benefits of percutaneous interventions in select cases. It is essential to recognize, however, that the choice between surgical and percutaneous closure depends on various factors, including the patient’s overall health, the extent of the septal rupture, and associated cardiac abnormalities.
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Administration of a pharmaceutical agent
Loop Diuretics
VSR can lead to acute heart failure, causing pulmonary congestion. Loop diuretics act on the loop of Henle in the kidneys to increase the excretion of sodium and water.
This diuretic effect helps reduce fluid volume, alleviating pulmonary congestion and improving respiratory symptoms such as dyspnea.
Loop diuretics provide symptomatic relief by addressing common manifestations of heart failure, such as shortness of breath, fatigue, and edema.
The goal is to enhance the patient’s comfort and overall well-being while preparing for definitive surgical intervention.
Opioid Analgesics
Pain management is important, especially if the patient experiences chest discomfort or pain related to the initial myocardial infarction. Opioid or non-opioid analgesics may be used as appropriate.
Anti-arrythmic
Arrhythmias may accompany VSR. Antiarrhythmic medications, such as amiodarone, may be used to control rhythm disturbances and stabilize the heart’s electrical activity.
Anticoagulants
Anticoagulation may be initiated to prevent thrombus formation, particularly in the setting of acute myocardial infarction and the increased risk of clot formation.
»
Home » CAD » Post-infarction ventricular septal rupture
Post-infarction ventricular septal rupture
Updated :
December 8, 2023
Postinfarction ventricular septal rupture (VSR) is a serious and potentially life-threatening complication that can occur after a myocardial infarction.
The clinical manifestations of these complications vary and are contingent on the location of the rupture, which can affect the free wall of either the ventricle, the interventricular septum, or the papillary muscles.
Post-myocardial infarction VSR is a feared complication and is associated with significant morbidity and mortality in individuals experiencing ST-elevation myocardial infarction.
Post-myocardial infarction ventricular septal rupture (VSR) is observed in 1% to 2% of patients with ST-elevation myocardial infarction when reperfusion therapy is not administered and in 0.2% to 0.34% of patients receiving fibrinolytic therapy.
Among those undergoing reperfusion therapy, the occurrence is more frequent in individuals treated with fibrinolytic therapy than percutaneous coronary intervention. The incidence of VSR rises to 3.8% in STEMI patients experiencing cardiogenic shock as a complication.
The pathophysiology of postinfarction ventricular septal rupture (VSR) is rooted in the aftermath of a myocardial infarction. In the context of postinfarction VSR, the ventricular septum, which is the muscular wall separating the left and right ventricles of the heart, becomes particularly vulnerable. The infarction-induced ischemia weakens the septum, making it susceptible to rupture.
This weakening process is exacerbated by the inflammatory response and enzymatic activity associated with myocardial infarction. As the ventricular septum weakens, the pressure within the left ventricle increases. The combination of heightened pressure and structural vulnerability can lead to the formation of a tear or rupture in the septum. This rupture creates a direct communication between the left and right ventricles, allowing blood to flow between these chambers.
The pathophysiological consequences of postinfarction VSR are profound. The abnormal communication disrupts the normal flow of blood within the heart, leading to complications such as acute heart failure, pulmonary edema, and cardiogenic shock. The severity of these complications is often contingent on the size and location of the septal rupture.
Ventricular septal rupture (VSR) is prevalent in an older demographic, particularly among females, those with hypertension, individuals with chronic kidney disease, and those without a history of smoking. It frequently manifests in the context of a primary myocardial infarction when reperfusion therapy is delayed or unavailable.
Angiographic assessments typically reveal an absence of collateral circulation to the infarct zone. The incidence of VSR tends to be higher in individuals experiencing their first myocardial infarction, especially when reperfusion therapy is not promptly administered. Notably, the absence of prior smoking history further contributes to the likelihood of VSR occurrence.
Contrarily, patients with documented evidence of diabetes mellitus, chronic angina, or a history of previous myocardial infarction exhibit a reduced propensity for septal rupture. This diminished risk is attributed to the protective effects of myocardial preconditioning induced by prior ischemic events, which decreases the likelihood of extensive myocardial necrosis and subsequent septal rupture.
VSR is associated with high morbidity and mortality rates. Early surgical intervention is crucial for improving outcomes. VSR is reported to occur more commonly in individuals treated with fibrinolytic therapy as opposed to percutaneous coronary intervention.
Patients with ventricular septal rupture (VSR) often have a history of recent myocardial infarction (MI). The clinical history may include details about the type of MI (ST-elevation myocardial infarction or non-ST-elevation myocardial infarction), any delays in receiving reperfusion therapy, and the presence of other cardiovascular risk factors.
VSR commonly presents with signs of cardiogenic shock, characterized by hypotension, tachycardia, and inadequate tissue perfusion. This is a critical manifestation reflecting the hemodynamic impact of the septal rupture. Patients may experience dyspnea, reflecting the development of acute heart failure and pulmonary congestion.
Due to compromised cardiac output, patients may exhibit symptoms of fatigue, weakness, and exercise intolerance. While the initial myocardial infarction may have presented with chest pain, the rupture of the ventricular septum may contribute to persistent or recurrent chest discomfort.
One of the hallmark signs of VSR is the presence of a new holosystolic murmur. This murmur is typically heard at the lower left sternal border and may radiate to other areas of the chest. It is a result of the abnormal communication between the left and right ventricles caused by the septal rupture. Due to the hemodynamic consequences of VSR, patients often exhibit tachycardia.
The heart rate may be out of proportion to the degree of fever if present. VSR can lead to hemodynamic instability, resulting in low blood pressure. In advanced cases, jugular venous distension may be observed, reflecting increased central venous pressure due to compromised cardiac output. The presence of crackles on lung auscultation may indicate the development of pulmonary edema.
This occurs as a consequence of acute heart failure and the backflow of blood into the lungs. Edema in the extremities, particularly in the ankles and lower legs, may be present due to fluid retention and congestion resulting from heart failure. Hepatojugular reflux, characterized by an increase in jugular venous pressure upon sustained pressure applied to the liver, may be observed. This is another sign of increased right-sided heart pressure.
Myocardial Infarction
Infective Endocarditis
Pericardial Tamponade
The treatment of ventricular septal rupture (VSR) is primarily centered around urgent surgical closure, representing the gold standard intervention. Prompt surgical repair is crucial to address the communication between the left and right ventricles, mitigate hemodynamic compromise, and reduce associated morbidity and mortality.
Some considerations, such as allowing for tissue healing before surgery, have been debated, but the reported lower surgical mortality rates may be influenced by selection bias. Surgical mortality tends to be higher in patients with inferior myocardial infarction (MI) compared to those with anterior infarcts, attributed to more significant technical challenges and the frequent need for concomitant mitral valve repair in cases of basal septal rupture with coexisting mitral regurgitation.
While surgery remains the dominant approach, there is a growing interest in percutaneous closure, especially in patients with high surgical risk, reflecting a shift in therapeutic strategies. The choice between surgical and percutaneous closure is nuanced. It depends on factors such as the patient’s overall health and the specific characteristics of the septal rupture and associated cardiac abnormalities.
The preferred treatment for ventricular septal rupture (VSR) is urgent surgical closure. Some researchers propose that delaying surgery may allow for the healing of delicate tissue, potentially reducing surgical mortality. However, it is important to note that reported lower surgical mortality rates could be influenced by selection bias.
Among patients with inferior myocardial infarction (MI), the surgical mortality rate is notably higher at 70%, in contrast to patients with anterior infarcts, where the mortality rate is around 30%. This discrepancy is attributed to the increased technical challenges associated with basal septal rupture in inferior MI cases, often necessitating concomitant mitral valve repair due to the frequent presence of coexisting mitral regurgitation.
Despite surgery being the established gold standard for post-MI VSR, there is a growing trend towards attempting percutaneous closure, particularly in patients deemed to be at high surgical risk. This reflects a shift in therapeutic approaches, acknowledging the potential benefits of percutaneous interventions in select cases. It is essential to recognize, however, that the choice between surgical and percutaneous closure depends on various factors, including the patient’s overall health, the extent of the septal rupture, and associated cardiac abnormalities.
Loop Diuretics
VSR can lead to acute heart failure, causing pulmonary congestion. Loop diuretics act on the loop of Henle in the kidneys to increase the excretion of sodium and water.
This diuretic effect helps reduce fluid volume, alleviating pulmonary congestion and improving respiratory symptoms such as dyspnea.
Loop diuretics provide symptomatic relief by addressing common manifestations of heart failure, such as shortness of breath, fatigue, and edema.
The goal is to enhance the patient’s comfort and overall well-being while preparing for definitive surgical intervention.
Opioid Analgesics
Pain management is important, especially if the patient experiences chest discomfort or pain related to the initial myocardial infarction. Opioid or non-opioid analgesics may be used as appropriate.
Anti-arrythmic
Arrhythmias may accompany VSR. Antiarrhythmic medications, such as amiodarone, may be used to control rhythm disturbances and stabilize the heart’s electrical activity.
Anticoagulants
Anticoagulation may be initiated to prevent thrombus formation, particularly in the setting of acute myocardial infarction and the increased risk of clot formation.
medtigo
Post-infarction ventricular septal rupture
Updated :
December 8, 2023
Postinfarction ventricular septal rupture (VSR) is a serious and potentially life-threatening complication that can occur after a myocardial infarction.
The clinical manifestations of these complications vary and are contingent on the location of the rupture, which can affect the free wall of either the ventricle, the interventricular septum, or the papillary muscles.
Post-myocardial infarction VSR is a feared complication and is associated with significant morbidity and mortality in individuals experiencing ST-elevation myocardial infarction.
Post-myocardial infarction ventricular septal rupture (VSR) is observed in 1% to 2% of patients with ST-elevation myocardial infarction when reperfusion therapy is not administered and in 0.2% to 0.34% of patients receiving fibrinolytic therapy.
Among those undergoing reperfusion therapy, the occurrence is more frequent in individuals treated with fibrinolytic therapy than percutaneous coronary intervention. The incidence of VSR rises to 3.8% in STEMI patients experiencing cardiogenic shock as a complication.
The pathophysiology of postinfarction ventricular septal rupture (VSR) is rooted in the aftermath of a myocardial infarction. In the context of postinfarction VSR, the ventricular septum, which is the muscular wall separating the left and right ventricles of the heart, becomes particularly vulnerable. The infarction-induced ischemia weakens the septum, making it susceptible to rupture.
This weakening process is exacerbated by the inflammatory response and enzymatic activity associated with myocardial infarction. As the ventricular septum weakens, the pressure within the left ventricle increases. The combination of heightened pressure and structural vulnerability can lead to the formation of a tear or rupture in the septum. This rupture creates a direct communication between the left and right ventricles, allowing blood to flow between these chambers.
The pathophysiological consequences of postinfarction VSR are profound. The abnormal communication disrupts the normal flow of blood within the heart, leading to complications such as acute heart failure, pulmonary edema, and cardiogenic shock. The severity of these complications is often contingent on the size and location of the septal rupture.
Ventricular septal rupture (VSR) is prevalent in an older demographic, particularly among females, those with hypertension, individuals with chronic kidney disease, and those without a history of smoking. It frequently manifests in the context of a primary myocardial infarction when reperfusion therapy is delayed or unavailable.
Angiographic assessments typically reveal an absence of collateral circulation to the infarct zone. The incidence of VSR tends to be higher in individuals experiencing their first myocardial infarction, especially when reperfusion therapy is not promptly administered. Notably, the absence of prior smoking history further contributes to the likelihood of VSR occurrence.
Contrarily, patients with documented evidence of diabetes mellitus, chronic angina, or a history of previous myocardial infarction exhibit a reduced propensity for septal rupture. This diminished risk is attributed to the protective effects of myocardial preconditioning induced by prior ischemic events, which decreases the likelihood of extensive myocardial necrosis and subsequent septal rupture.
VSR is associated with high morbidity and mortality rates. Early surgical intervention is crucial for improving outcomes. VSR is reported to occur more commonly in individuals treated with fibrinolytic therapy as opposed to percutaneous coronary intervention.
Patients with ventricular septal rupture (VSR) often have a history of recent myocardial infarction (MI). The clinical history may include details about the type of MI (ST-elevation myocardial infarction or non-ST-elevation myocardial infarction), any delays in receiving reperfusion therapy, and the presence of other cardiovascular risk factors.
VSR commonly presents with signs of cardiogenic shock, characterized by hypotension, tachycardia, and inadequate tissue perfusion. This is a critical manifestation reflecting the hemodynamic impact of the septal rupture. Patients may experience dyspnea, reflecting the development of acute heart failure and pulmonary congestion.
Due to compromised cardiac output, patients may exhibit symptoms of fatigue, weakness, and exercise intolerance. While the initial myocardial infarction may have presented with chest pain, the rupture of the ventricular septum may contribute to persistent or recurrent chest discomfort.
One of the hallmark signs of VSR is the presence of a new holosystolic murmur. This murmur is typically heard at the lower left sternal border and may radiate to other areas of the chest. It is a result of the abnormal communication between the left and right ventricles caused by the septal rupture. Due to the hemodynamic consequences of VSR, patients often exhibit tachycardia.
The heart rate may be out of proportion to the degree of fever if present. VSR can lead to hemodynamic instability, resulting in low blood pressure. In advanced cases, jugular venous distension may be observed, reflecting increased central venous pressure due to compromised cardiac output. The presence of crackles on lung auscultation may indicate the development of pulmonary edema.
This occurs as a consequence of acute heart failure and the backflow of blood into the lungs. Edema in the extremities, particularly in the ankles and lower legs, may be present due to fluid retention and congestion resulting from heart failure. Hepatojugular reflux, characterized by an increase in jugular venous pressure upon sustained pressure applied to the liver, may be observed. This is another sign of increased right-sided heart pressure.
Myocardial Infarction
Infective Endocarditis
Pericardial Tamponade
The treatment of ventricular septal rupture (VSR) is primarily centered around urgent surgical closure, representing the gold standard intervention. Prompt surgical repair is crucial to address the communication between the left and right ventricles, mitigate hemodynamic compromise, and reduce associated morbidity and mortality.
Some considerations, such as allowing for tissue healing before surgery, have been debated, but the reported lower surgical mortality rates may be influenced by selection bias. Surgical mortality tends to be higher in patients with inferior myocardial infarction (MI) compared to those with anterior infarcts, attributed to more significant technical challenges and the frequent need for concomitant mitral valve repair in cases of basal septal rupture with coexisting mitral regurgitation.
While surgery remains the dominant approach, there is a growing interest in percutaneous closure, especially in patients with high surgical risk, reflecting a shift in therapeutic strategies. The choice between surgical and percutaneous closure is nuanced. It depends on factors such as the patient’s overall health and the specific characteristics of the septal rupture and associated cardiac abnormalities.
The preferred treatment for ventricular septal rupture (VSR) is urgent surgical closure. Some researchers propose that delaying surgery may allow for the healing of delicate tissue, potentially reducing surgical mortality. However, it is important to note that reported lower surgical mortality rates could be influenced by selection bias.
Among patients with inferior myocardial infarction (MI), the surgical mortality rate is notably higher at 70%, in contrast to patients with anterior infarcts, where the mortality rate is around 30%. This discrepancy is attributed to the increased technical challenges associated with basal septal rupture in inferior MI cases, often necessitating concomitant mitral valve repair due to the frequent presence of coexisting mitral regurgitation.
Despite surgery being the established gold standard for post-MI VSR, there is a growing trend towards attempting percutaneous closure, particularly in patients deemed to be at high surgical risk. This reflects a shift in therapeutic approaches, acknowledging the potential benefits of percutaneous interventions in select cases. It is essential to recognize, however, that the choice between surgical and percutaneous closure depends on various factors, including the patient’s overall health, the extent of the septal rupture, and associated cardiac abnormalities.
Loop Diuretics
VSR can lead to acute heart failure, causing pulmonary congestion. Loop diuretics act on the loop of Henle in the kidneys to increase the excretion of sodium and water.
This diuretic effect helps reduce fluid volume, alleviating pulmonary congestion and improving respiratory symptoms such as dyspnea.
Loop diuretics provide symptomatic relief by addressing common manifestations of heart failure, such as shortness of breath, fatigue, and edema.
The goal is to enhance the patient’s comfort and overall well-being while preparing for definitive surgical intervention.
Opioid Analgesics
Pain management is important, especially if the patient experiences chest discomfort or pain related to the initial myocardial infarction. Opioid or non-opioid analgesics may be used as appropriate.
Anti-arrythmic
Arrhythmias may accompany VSR. Antiarrhythmic medications, such as amiodarone, may be used to control rhythm disturbances and stabilize the heart’s electrical activity.
Anticoagulants
Anticoagulation may be initiated to prevent thrombus formation, particularly in the setting of acute myocardial infarction and the increased risk of clot formation.
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
